Buscar
Regentis Biomaterials Ord Shs
RGNTAñadir a la lista de seguimiento
1.750USD
-0.050-2.78%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
0.00Cap. mercado
--P/E TTM
Más Datos de Regentis Biomaterials Ord Shs Compañía
Regentis Biomaterials Ltd is an Israel-based regenerative medicine company. The Company is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Its lead product is GellinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage. Its implant combines the precision of photopolymerization with the biocompatibility of PEG and fibrinogen, enabling natural tissue regeneration without the need for cell harvesting or culturing. Regentis Biomaterials Ltd aims to address unmet clinical needs in sports medicine and early-stage osteoarthritis.
Información de Regentis Biomaterials Ord Shs
Símbolo de cotizaciónRGNT
Nombre de la empresaRegentis Biomaterials Ltd
Fecha de salida a bolsaDec 04, 2025
Director ejecutivoHazum (Eli)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscal- -
Dirección60, Medinat Hyahudim
CiudadHERZLIYA
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísIsrael
Código postal4676652
Teléfono97246265502
Sitio Webhttps://www.regentis.co.il/
Símbolo de cotizaciónRGNT
Fecha de salida a bolsaDec 04, 2025
Director ejecutivoHazum (Eli)
Ejecutivos de Regentis Biomaterials Ord Shs
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Pini Ben-Elazar
Mr. Pini Ben-Elazar
Independent Director Nominee
Independent Director Nominee
73.54K
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Arie Gordashnikov, CPA
Mr. Arie Gordashnikov, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jeff Dykan, CPA
Mr. Jeff Dykan, CPA
Director
Director
--
--
Dr. Susan Alpert, M.D., Ph.D.
Dr. Susan Alpert, M.D., Ph.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Catherine C. (Keith) Valentine
Mr. Catherine C. (Keith) Valentine
Independent Director
Independent Director
--
--
Mr. Efraim Cohen-Arazi
Mr. Efraim Cohen-Arazi
Independent Director Nominee
Independent Director Nominee
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Pini Ben-Elazar
Mr. Pini Ben-Elazar
Independent Director Nominee
Independent Director Nominee
73.54K
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Arie Gordashnikov, CPA
Mr. Arie Gordashnikov, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jeff Dykan, CPA
Mr. Jeff Dykan, CPA
Director
Director
--
--
Dr. Susan Alpert, M.D., Ph.D.
Dr. Susan Alpert, M.D., Ph.D.
Independent Director Nominee
Independent Director Nominee
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Regentis Biomaterials Ord Shs?
Los cinco principales accionistas de Regentis Biomaterials Ord Shs son: Mr. Pini Ben-Elazar